INTRODUCTION
The expression of catabolite-repressible operons in Escherichia coli is cyclic AMP-dependent. It is mediated via the cyclic AMP receptor protein (CRP) which, when complexed with cyclic AMP, binds to specific sequences in the promotor region of the respective genes (for a recent review see Busby, 1986) . CRP is composed of two identical subunits of 209 amino acids (Aiba et al., 1982; Cossart & Gicquel-Sanzey, 1982) , each of which is divided into a structural and a functional domain: the larger N-terminal domain carries the cyclic AMP binding site and is involved in subunit-subunit interaction, while the smaller C-terminal domain is responsible for sequence-specific DNA binding (Eilen et al., 1978; McKay & Steitz, 1981) . On binding cyclic AMP the protein undergoes a defined conformational change such that the complex is capable of activating transcription (Krakow & Pastan, 1973; Wu et al., 1974) . Although a large number of cyclic nucleotide analogues can bind CRP, only a few are able to induce the correct conformational change required to activate transcription. These are 1-, 3-or 7-deaza-cyclic AMP, 2-and 8-azacyclic AMP, as well as the two cyclic AMP-S diastereomers (Ebright et al., 1985) . From the crystal structure of the cyclic AMP-CRP complex contacts between CRP residues and the bound nucleotide have been identified (McKay et al., 1982) . These contacts, however, had to be revised (Ebright, 1986) as the incorrect enantiomorph of cyclic AMP was erroneously fitted in the structure. Further, whereas cyclic AMP is found in the anti-conformation in the crystal structure (McKay & Steitz, 1981) , the cyclic nucleotide conformation of the complex in solution is syn (Gronenborn & Clore, 1982) .
In order to understand the allosteric change brought about by cyclic AMP, several laboratories have investigated CRP mutants which function in vivo in the absence of cyclic AMP. These mutations have been called a variety of names, most commonly crp* (Sanders & McGeoch, 1973; Botsford & Drexler, 1978; Melton et al., 1981) . They have been categorized into two classes: class I mutants can be stimulated by either cyclic AMP or cyclic GMP, while class II mutants do not respond to cyclic nucleotides at all (Aiba et al., 1985) . Determination of the sequences of a number of these mutants has shown that most of the crp* mutants are located at the end of helix C or the beginning of helix D, thus in a region which may be crucial for the reorientation of the Cterminal domain with respect to the N-terminal part of the protein (Garges & Adhya, 1985; Aiba et al., 1985; Harman et al., 1986) . It has therefore been argued that these mutant proteins have already achieved the 'active' conformation in the uncomplexed state (Garges & Adhya, 1985; Anderson, 1986) .
We have used oligonucleotide directed mutagenesis selectively to change amino acids in CRP (Gent et al., 1987a,b) and determine which amino acids are important for its function. In this paper we have extended our previous studies to the cyclic AMP binding site of CRP and focus on amino acids which have been proposed as important contacts between the protein and the cyclic nucleotide (McKay et al., 1982; Ebright, 1986) . Five residues were investigated, four of which were thought to interact specifically with the cyclic nucleotide, either with the cyclic phosphate moiety (Arg-82, Ser-83) or the adenine ring . The fifth residue (Ser-62) was chosen, because, although not directly interacting with the cyclic nucleotide, it is located on a stretch of polypeptide chain comprising residues 61 to 64 on ,-strand 5 which lines one side of the binding pocket. The amino acid changes carried out consisted of removing the functional group, i.e. Ser -+ Ala, or Arg -+ Leu. In the case of Ser-83, two amino acid substitutions were made, one which removed the supposedly hydrogen bonding OH (Ala), and a second in which the polar, small Ser sidechain 'was reptaced by a bulky positively charged one mutant genes were tested for sugar fermentation patterns, which reflects transcription activity and cyclic nucleotide binding. (Viera & Messing, 1982) which carries the crp structural gene on a 750 bp HindIII/EcoRV fragment inserted into the multiple cloning site. Site-directed mutagenesis CRP mutants were constructed by the gapped duplex method (Kramer et al., 1984) using single-stranded MI 3mp9 carrying the crp gene on a 750 bp fragment as a template. Approx. 20 base long oligonucleotides were used as mutagenic primers, carrying the desired mismatches approximately in the middle of their sequence (but slightly shifted towards the 3' end). Phage harbouring the mutations were initially identified by dot blot hybridization using the 32P-labelled oligonucleotide as a probe. The frequency of mutation was between 10 % and 30 %. After plaque purification the single strand of a mutant clone .was sequenced by the dideoxy method (Sanger et al., 1977) to establish that the desired mutations were the sole ones within the entire coding region. The mutated crp gene was subsequently cloned into the plasmid pUC9 and the recombinant plasmids were used for transformation of the CRP-deficient strains pp47 or TP2339. The sequence of the mutant gene in the plasmid was again checked by sequencing (Chen & Seeburg, 1985) . Sugar utilization test Sugar utilization was tested on EMB agar containing 1 % of the respective sugar, 50 jtg of ampicillin/ml and cyclic nucleotides or other added supplements as indicated.
P-Galactosidase assay
Cells were grown in EMB medium containing lactose. When the optical density at 600 nm reached 0.5-1.0, 0.5 absorbance units were removed, centrifuged and the cells resuspended. fl-Galactosidase activity was determined according to Miller (1972) . Cyclic AMP binding assay Cyclic AMP binding was determined using the (NH4)SO4 precipitation procedure as described by Anderson et al. (1971) either in crude extracts or for purified protein. The equilibrium binding curves were fitted to a rectangular hyperbola: counts in pellet = S -Kapp. [cAMP] (1 + Kapp. [cAMP]) where K is the apparent equilibrium association constant,acAMP] the concentration of added cyclic AMP (note that [cAMP] > [CRP]), and S a scale factor. Fitting was performed using the FACSIMILE program (Chance et al., 1977) which employs Powell's method of non-linear optimization (Powell, 1972) . Table 1 lists the plasmids constructed and used in our investigation as well as the corresponding amino acid changes. All of these result in the production of CRP protein when introduced into a crp-host strain, with the obvious exception of the parent plasmid pUC9. This is easily appreciated from the gel shown in Fig. 1 , on which the total soluble proteins of overnight cultures of pp47 harbouring the various plasmids are separated. Comparable amounts of CRP are found in all cases. The protein is expressed from the lac promoter using its own ribosome binding site. A possible interference by CRP autoregulation (Aiba, 1983) Table 3 . A similar pattern, though not as pronounced, was obtained for maltose. Lactose utilization could not be tested as this strain also carries a deletion of the lac gene. As can be seen from the results all plasmids which were able to compensate for the lack of CRP in the crp-strain showed positive fermentation patterns in the presence of exogenously supplied cyclic AMP. We also tested other cyclic nucleotides for their ability to activate galactose expression. Cyclic GMP gave negative responses for all plasmids tested, as did 8-Brcyclic AMP. The two isomers of cyclic AMP-S, however, were able to activate the sugar operons with the wildtype plasmid already showing a positive response at a concentration of 0.02 mm for the Rp isomer; the Sp isomer, on the other hand required a higher concentration (> 2 mM) than cyclic AMP for activation.
RESULTS

Expression of mutant protein
Under normal circumstances CRP-dependent operon expression is repressed by glucose (Monod, 1947 ; for a recent review see Postma, 1986 ), a phenomenon known as catabolite repression which is thought to be caused by lowering of cyclic AMP levels leading to the dissociation of the active CRP-cyclic AMP complex. To test for catabolite repression we examined sugar utilization (lactose, galactose and maltose) as a function of added amethyl-glucoside (10-100 mM), a non-hydrolysable PTS carbohydrate. At 10 mm some lowering of lac expression is observed, while for gal the effect is visible only from 20 mm upwards. In general, however, these effects are small, i.e. the strong positive lac and gal expression, as manifested by a green shine on EMB plates, is reduced to either dark purple (gal) or to a weak green shine (mal). /I-Galactosidase activity Lac promotor activity for the various mutants was also measured by the f6-galactosidase assay. The average of three independent measurements is summarized in (Anderson et al., 1971) . Approximate In addition to a high expression level of CRP as seen from the gel shown in Fig. 1 From the results of the cyclic nucleotide dependence of fermentation patterns summarized in Table 3 , it is clear that in those cases where the mutant CRP is able to bind cyclic AMP, exogenous addition of it will lead to a positive response. Further, the relative binding strength of the different cyclic AMP-S analogues can also be demonstrated. It has been established that cyclic AMP-S (Rp isomer) binds much better to wild-type CRP than cyclic AMP, which in turn binds better than cyclic AMP-S (Sp isomer) (Ebright, 1986) . This is very clearly reflected on the EMB/galactose plates supplemented with the respective cyclic nucleotide. While gal activation is already seen at 0.02 mM-cyclic AMP-S (Rp isomer), the same activation level requires 0.5 mM-cyclic AMP or > 2 mM-cyclic AMP-S (Sp isomer). Results obtained with some of the mutants, e.g. agl (Ser-83 -* Ala), showed an identical pattern; however, all concentrations were up by a factor of 10. It is interesting to note that very similar ratios were found for cyclic nucleotide-induced figalactosidase stimulation, namely cyclic AMP-S (Rp) > cAMP > cAMP-S (Sp) (Scholibbers et al., 1984) . We also tested for cyclic AMP and 8-Br-cyclic AMP dependence of gal activation and found the same results for all mutants as was known for wild-type CRP, namely that these cyclic nucleotide analogues are not able to promote the allosteric transition required for activity (Ebright et al., 1985) . Thus all changes introduced into the protein by mutagenesis did not alter the known cyclic nucleotide selectivity of the wild-type protein.
Functional amino acids in the cyclic AMP binding pocket How can the observed changes in activity be interpreted in terms of structure of the cyclic AMP binding site? The latest model for the interactions between CRP and cyclic AMP was presented by Weber et al. (1987) , and a modification of their model is schematically illustrated in Fig. 2 Weber et al. (1987) , taking into account the results of the present study. In particular the Ser-83 hydroxyl is no longer hydrogen bonded to the axial phosphate oxygen. Instead the bidentate Arg-82 guanidinium group forms an ion pair with the negative phosphate comprising both the axial and equatorial oxygens. Hydrogen bonds between Thr-127 and Ser-128 on the one hand, and the 6-amino group of the adenine ring on the other, are still indicated although they may not necessarily be present.
The proposed interaction of the Ser-83 hydroxyl with the axial phosphate oxygen cannot be very important since both substitutions of Ser-83 by Lys or Leu do not abolish binding but only lower the binding constant, possibly by interfering with the correct positioning of cyclic AMP due to steric hindrance. If the Ser hydroxyl group really would be responsible for the better binding ofcyclic AMP-S (Rp) to CRP, both mutants in which this hydroxyl is no longer present, namely agl (Ser-83 -. Ala) and ag2 (Ser-83 -* Lys), should have lost this selectivity. This is clearly not the case, as can be judged from the data presented in Table 3 . Cyclic AMP-S (Rp) activates gal transcription in the AcrpAcya strain carrying agl or ag2 already to the fullest level of 0.2 mm, whereas 20 mM exogenously added cyclic AMP are necessary for the same level of activation.
From the crystallographic model it is not easily appreciated why ag4 (Ser-62 -. Ala) is a better activator than the wild-type protein. The Ser hydroxyl is pointing away from the cyclic nucleotide binding site being in rather close contact with Val-49. Thus, the improvement in the binding of cyclic AMP may be solely due to the removal of a bad steric contact between amino acids lining the binding site rather than a direct positive interaction between Ala-62 and the cyclic nucleotide. It is interesting to note that there already exists a mutant at position 62. This is one of the crp* mutants isolated by Aiba et al. (1985) and consists of a Ser -* Phe change. In contrast to our mutant, this mutant can only be activated at higher cyclic AMP concentrations (Aiba et al., 1985) . It seems unlikely that the bulky Phe side-chain could occupy the same position as the Ser or the Ala. The aromatic phenyl ring may actually slot into the cyclic AMP binding site, which in turn could result in a similar conformational change to that produced in the wild-type case by cyclic AMP, thereby rendering this protein independent of the cyclic nucleotide.
Mutants ag5 (Thr-127 --+Ala) and CAP4 Ala) were constructed in order to test the proposed contacts with the adenine base. Both Thr-127 and Ser-128, with the latter from the adjacent subunit, supposedly hydrogen bond to the 6-amino group on the adenine ring; the threonine hydroxyl interacts with the amino hydrogen pointing towards N-I and the serine hydroxyl interacts with the amino hydrogen on the N-7 side as well as with the N-7 on the adenine ring (McKay et al., 1982) .
As evidenced by the binding data for cyclic AMP as well as the activity in vivo of both mutants, both amino acids are not crucial for the binding of cyclic AMP. Nevertheless, they have some effect on transcription since gal activation in both cases requires higher cyclic AMP levels than was found for wild-type CRP. We believe that the actual binding constant of cyclic AMP binding to the mutant proteins could be reduced, although they appear to be approximately similar to wild-type in the (NH4)2-S04 precipitation assay. On the other hand the effects seen could also be due to conformational differences between the wild type and mutant proteins. As can be seen from the data in Table 3 , the Ser-128 -. Ala change shows a lower activity than the Thr-127 -+Ala substitution. Both, however, can be activated by high levels of cyclic AMP and in turn activate the respective sugar operons. Ag5 (Thr-127 -. Ala) needs a 10 times higher cyclic AMP concentration than that required to activate the wild-type protein, while CAP4 (Ser-128 -. Ala) seems to require even more. This factor of 10, as discussed before, represents a gross overestimation of the difference in binding constant, which probably is only small and may have its origin in differences leading to the conformational changes required for transcription activation. From the fact that in the crp-strain both mutants can activate transcription of sugar operons, it is obvious that cyclic AMP does indeed bind to CRP mutant proteins and induces the active conformation. Furthermore, DNA binding experiments in vivo with CAP4 confirmed that this mutant binds to the lac site with comparable affinity (Kapp -8 x 107 mw1) as compared to wild-type CRP (Kapp 108 M-') (Gent et al., 1987b) and is able to induce transcription from the correct lac promoter (unpublished results). It is therefore our belief that neither ag5 (Thr-1 27 -. Ala) nor CAP4 (Ser-128 -+ Ala) exhibit differences in cyclic AMP binding constants large enough to reflect the loss of a hydrogen bond. The small changes observed may solely be due to minor conformational differences in the two mutant proteins which in turn will have effects on cyclic AMP and/or DNA binding.
In view of the results obtained from extensive studies with cyclic nucleotide analogues (Ebright et al., 1985) , it seems clear that analogues modified at N-6 can bind to CRP, can induce the correct allosteric conformational change but fail to activate transcription. Since this modification comprises the N-I directed hydrogen atom of the 6-amino group, it seems likely that the N-7 directed hydrogen is the one responsible for any interaction. This is thought to be in contact with Ser-128, and it is the Ser-128 -. Ala mutation which requires the largest amount of cyclic AMP for activation. The proposed interaction between Ser-128 and the N-7 position has already been disproved since 7-deaza-cyclic AMP is as, or more, potent than cyclic AMP in binding and activity (Ebright et al., 1985) . Thus, although not as crucial for binding as Arg-82, which presumably provides most of the binding energy, Ser-128 may play a minor role in producing the right conformation for optimal binding.
